Hello friends,
I have just posted the first part of my interview with Dr. Wiestner on his research on ibrutinib.
His interviews will be the last from ASH 2012, as I look forward to going to ASCO 2013 and learning and sharing from that. Things are moving fast.
Please take a look at bkoffman.blogspot.com and learn from Dr. Wiestner, but also please comment on my thoughts about ASCO and what you might want to know that I didn't cover.
Thanks and stay strong.
We are all in this together
Brian
Hi please keep the videos coming for all those of us who cannot be there in person.
ASH 2018: Dr. Chadi Nabhan on the Cost of Ibrutinib vs. Chemo vs Chemoimmunotherapy in CLL and on way too much chemo being used.
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCODr. Furman on the Diminishing Role of FCRDr. Fauci shares his recommendation that immunosuppressed patients with blood cancers, like us, get the vaccine, because some immunity is be
